Today's top medical abstracts
Endocrinology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Endocrinology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Endocrinology
        Adrenal Glands
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Bone Metabolism
        Diabetes
        Diagnostics
        Economics of Medicine
        Endocrine Oncology
        Fetal Development
        Hypertension
        Metabolism and Growth
        Neuroendocrinology
        Obesity
        Pediatric Endocrinology
        Pharmacology/kinetics
        Popular Press
        Primary Care
        Reproductive
    Endocrinology
        Thyroid/Parathyroid
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
FDA Update: Thyrotropin Approved For Thyroid Cancer Ablation
Tracy Hampton, PhD, MDLinx Oncology
  See all
Antiserum directed against chromogranin A and B (CAB) Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Antiserum directed against chromogranin A and B (CAB) is a useful marker for peptide hormone-producing endocrine cells and tumors
Endocrine Pathology, 07/02/08
Print     Email This Article     Save in My Library   Free Abstract
Larsson L et al. - Chromogranin A and B (CAB) antiserum may help identify peptide hormone-producing cells and tumors

Methods

  • Study of an antiserum that recognizes both chromogranin A and B (CAB) to show peptide hormone-producing endocrine cells and tumors in humans

Results
  • Antiserum showed endocrine cells along the gastrointestinal tract, most islet cells, adrenomedullary cells, thyroid C cells, scattered endocrine cells in the respiratory tract, and numerous cells in the adenohypophysis
  • CAB-positive cells outnumbered those storing chromogranin A in intestines and anterior pituitary
  • Also CAB-positive was an array of different peptide hormone-producing tumor cells: several types of islet cell tumors; gastric, intestinal, and bronchial carcinoids; medullary thyroid carcinomas; pheochromocytomas

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.